Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study.

Kordon A, Wahl K, Koch N, Zurowski B, Anlauf M, Vielhaber K, Kahl KG, Broocks A, Voderholzer U, Hohagen F.

J Clin Psychopharmacol. 2008 Oct;28(5):550-4. doi: 10.1097/JCP.0b013e318185e735.

PMID:
18794652
[PubMed - indexed for MEDLINE]
2.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.

Mol Psychiatry. 2006 Jul;11(7):622-32. Epub 2006 Apr 4. Review. Erratum in: Mol Psychiatry. 2006 Aug;11(8):795.

PMID:
16585942
[PubMed - indexed for MEDLINE]
3.

[Efficacy of antipsychotic augmentation therapy in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomised, placebo-controlled trials].

Dold M, Aigner M, Lanzenberger R, Kasper S.

Fortschr Neurol Psychiatr. 2011 Aug;79(8):453-66. doi: 10.1055/s-0031-1273397. Epub 2011 Aug 1. Review. German.

PMID:
21809258
[PubMed - indexed for MEDLINE]
4.

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.

Dold M, Aigner M, Lanzenberger R, Kasper S.

Int J Neuropsychopharmacol. 2013 Apr;16(3):557-74. doi: 10.1017/S1461145712000740. Epub 2012 Aug 29. Review.

PMID:
22932229
[PubMed - indexed for MEDLINE]
5.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
[PubMed - indexed for MEDLINE]
6.

Pharmacological management of obsessive-compulsive disorder: a review for clinicians.

McDonough M, Kennedy N.

Harv Rev Psychiatry. 2002 May-Jun;10(3):127-37. Review.

PMID:
12023928
[PubMed - indexed for MEDLINE]
7.

Second-generation antipsychotics for obsessive compulsive disorder.

Komossa K, Depping AM, Meyer M, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008141. doi: 10.1002/14651858.CD008141.pub2. Review.

PMID:
21154394
[PubMed - indexed for MEDLINE]
8.

Escitalopram in the treatment of obsessive-compulsive disorder.

Zohar J.

Expert Rev Neurother. 2008 Mar;8(3):339-49. doi: 10.1586/14737175.8.3.339. Review.

PMID:
18345966
[PubMed - indexed for MEDLINE]
9.

Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.

Chouinard G.

Int Clin Psychopharmacol. 1992 Oct;7 Suppl 2:37-41. Review.

PMID:
1484177
[PubMed - indexed for MEDLINE]
10.

Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review.

Sareen J, Kirshner A, Lander M, Kjernisted KD, Eleff MK, Reiss JP.

J Affect Disord. 2004 Oct 15;82(2):167-74. Review.

PMID:
15488245
[PubMed - indexed for MEDLINE]
11.

Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.

Fineberg NA, Pampaloni I, Pallanti S, Ipser J, Stein DJ.

Int Clin Psychopharmacol. 2007 Nov;22(6):313-22. Review.

PMID:
17917549
[PubMed - indexed for MEDLINE]
12.

Antipsychotic treatment in obsessive-compulsive disorder: a literature review.

Keuneman RJ, Pokos V, Weerasundera R, Castle DJ.

Aust N Z J Psychiatry. 2005 May;39(5):336-43. Review.

PMID:
15860020
[PubMed - indexed for MEDLINE]
13.

A review of pharmacologic treatments for obsessive-compulsive disorder.

Kaplan A, Hollander E.

Psychiatr Serv. 2003 Aug;54(8):1111-8. Review.

PMID:
12883138
[PubMed - indexed for MEDLINE]
14.

Issues in the pharmacological treatment of obsessive-compulsive disorder.

Math SB, Janardhan Reddy YC.

Int J Clin Pract. 2007 Jul;61(7):1188-97. Epub 2007 May 18. Review.

PMID:
17511795
[PubMed - indexed for MEDLINE]
15.

Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

Goodman WK, Ward H, Kablinger A, Murphy T.

J Clin Psychiatry. 1997;58 Suppl 5:32-49. Review.

PMID:
9184625
[PubMed - indexed for MEDLINE]
16.

The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods.

Franklin M, Foa E, March JS.

J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S39-51. Review.

PMID:
12880499
[PubMed - indexed for MEDLINE]
17.

Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.

Dominguez RA.

J Clin Psychiatry. 1992 Oct;53 Suppl:56-9. Review.

PMID:
1429485
[PubMed - indexed for MEDLINE]
18.

Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

Dell'Osso B, Nestadt G, Allen A, Hollander E.

J Clin Psychiatry. 2006 Apr;67(4):600-10. Review.

PMID:
16669725
[PubMed - indexed for MEDLINE]
19.

[Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].

Nakamae T.

Seishin Shinkeigaku Zasshi. 2011;113(10):1016-25. Review. Japanese.

PMID:
22187889
[PubMed - indexed for MEDLINE]
20.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk